Medtronic Lowers Earnings Forecast Following MiniMed IPO

Thursday, Mar 26, 2026 4:00 pm ET1min read
MDT--
MMED--

Medtronic has lowered its FY26 earnings forecast after its diabetes spinoff, MiniMed, went public. The revised outlook includes a charge for future payments to private equity firm Blackstone, which funded development of MiniMed's new insulin pump. Medtronic now expects adjusted EPS of $5.50 to $5.54, a decrease of 12 cents from its previous forecast. The company expects dilution of one to two cents per month between the IPO and split.

Medtronic Lowers Earnings Forecast Following MiniMed IPO

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet